4D Molecular Therapeutics, Inc. (FDMT)
Nasdaq: FDMT · Biological Products, (No Diagnostic Substances) · Emeryville, CA · filing with the SEC since 2015
Who runs 4D Molecular Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
22 people on the record since 2020
Officerssales are open-market, Oct 20, 2025 to Oct 20, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bizily Scott | Chief Legal Officer | Mar 2022 | Oct 20, 2026 | 10 · $400,000 |
| Kirn David | See Remarks | Dec 2020 | Oct 7, 2026 | 12 · $5.0M |
| Simms Christopher Paul | Chief Commercial and Business Officer | Dec 2025 | Mar 27, 2026 | none |
| Gupta Ashoo | VP, Finance and Controller | Oct 2025 | Mar 24, 2026 | 4 · $0.00 |
| Humer Kristian | Chief Financial Officer | Dec 2025 | Dec 11, 2025 | none |
Directorssales are open-market, Oct 20, 2025 to Oct 20, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chacko Jacob | director | Dec 2020 | Jun 18, 2026 | none |
| Gray Susannah | director | Dec 2020 | Jun 18, 2026 | none |
| Miller-Rich Nancy | director | Dec 2020 | Jun 18, 2026 | none |
| Milligan John F | director | Dec 2020 | Jun 18, 2026 | none |
| Sblendorio Glenn | director | Jan 2026 | Jun 18, 2026 | none |
| Theuer Charles | director | Dec 2020 | Jun 18, 2026 | none |
| Tomasello Shawn | director | Dec 2020 | Jun 18, 2026 | none |
Earlier names on the record30, newest filing first
Kamal Fariborz · officer · last filing Mar 2025Mehra Uneek · officer · last filing Mar 2025Kim Robert Young · officer · last filing Mar 2025Kolchinsky Peter · 10% owner · last filing Dec 2024Ra Capital Healthcare Fund LP · 10% owner · last filing Dec 2024Ra Capital Management, L.P. · 10% owner · last filing Dec 2024Shah Rajeev M. · 10% owner · last filing Dec 2024Biotechnology Value Fund II LP · other · last filing Nov 2024Biotechnology Value Fund L P · other · last filing Nov 2024Biotechnology Value Trading Fund Os LP · other · last filing Nov 2024Bvf Gp Holdings LLC · 10% owner · last filing Nov 2024Bvf I Gp LLC · other · last filing Nov 2024Bvf II Gp LLC · other · last filing Nov 2024Bvf Inc/il · 10% owner · last filing Nov 2024Bvf Partners L P/il · 10% owner · last filing Nov 2024Bvf Partners Os Ltd. · other · last filing Nov 2024Lampert Mark N · 10% owner · last filing Nov 2024Halvorsen Ole Andreas · 10% owner · last filing Jan 2024Ott David C. · 10% owner · last filing Jan 2024Shabet Rose Sharon · 10% owner · last filing Jan 2024Viking Global Investors LP · 10% owner · last filing Jan 2024Viking Global Opportunities Gp LLC · 10% owner · last filing Jan 2024Viking Global Opportunities Illiquid Investments Sub-Master LP · 10% owner · last filing Jan 2024Kasahara Noriyuki · director · last filing May 2023Moretti August J · officer · last filing May 2023Fishman Robert S · officer · last filing Sep 2022Zimmermann Carolyne · officer · last filing Feb 2022Schaffer David · director · last filing Oct 2021Yao Tony Dung Ling · director · last filing Dec 2020Burkoth William T. · director · last filing Dec 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.